Jump to content

Polysaccharide–protein conjugate

From Wikipedia, the free encyclopedia

Polysaccharide–protein conjugates may have better solubility and stability, reduced immunogenicity, prolonged circulation time, and enhanced targeting ability compared to native protein.[1] They are promising alternatives to PEG–protein drugs, in which non-biodegradable high molecular weight PEG causes health concerns.[2]

Synthetic methods

[edit]

Reductive amination, the Maillard reaction, EDC/NHS coupling, DMTMM coupling, disulfide bond formation, and click chemistry are common methods to synthesize polysaccharide–protein conjugates.[1]

Applications

[edit]

Polysaccharide–protein conjugates are used for food industry, vaccines, and drug delivery systems.[3][4][5][6]

References

[edit]
  1. ^ a b Zhou, Yang; Petrova, Stella P.; Edgar, Kevin J. (2021-11-15). "Chemical synthesis of polysaccharide–protein and polysaccharide–peptide conjugates: A review". Carbohydrate Polymers. 274: 118662. doi:10.1016/j.carbpol.2021.118662. ISSN 0144-8617. PMID 34702481. S2CID 239999294.
  2. ^ Baumann, Andreas; Tuerck, Dietrich; Prabhu, Saileta; Dickmann, Leslie; Sims, Jennifer (2014-10-01). "Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?". Drug Discovery Today. 19 (10): 1623–1631. doi:10.1016/j.drudis.2014.06.002. ISSN 1359-6446. PMID 24929223.
  3. ^ Akhtar, Mahmood; Dickinson, Eric (2007-06-01). "Whey protein–maltodextrin conjugates as emulsifying agents: An alternative to gum arabic". Food Hydrocolloids. 21 (4): 607–616. doi:10.1016/j.foodhyd.2005.07.014. ISSN 0268-005X.
  4. ^ Perciani, Catia T.; Barazzone, Giovana C.; Goulart, Cibelly; Carvalho, Eneas; Cabrera-Crespo, Joaquin; Gonçalves, Viviane M.; Leite, Luciana C. C.; Tanizaki, Martha M. (2013-06-01). "Conjugation of Polysaccharide 6B from Streptococcus pneumoniae with Pneumococcal Surface Protein A: PspA Conformation and Its Effect on the Immune Response". Clinical and Vaccine Immunology. 20 (6): 858–866. doi:10.1128/CVI.00754-12. PMC 3675967. PMID 23554468.
  5. ^ Luo, Yanan; Wang, Xuenv; Du, Dan; Lin, Yuehe (2015-09-15). "Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery". Biomaterials Science. 3 (10): 1386–1394. doi:10.1039/C5BM00067J. ISSN 2047-4849. PMID 26301700.
  6. ^ Frasch, Carl E. (2009-10-30). "Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges". Vaccine. 27 (46): 6468–6470. doi:10.1016/j.vaccine.2009.06.013. ISSN 1873-2518. PMID 19555714.